in an accessible manner and encouraged to maintain lower body weights and higher 54 physical activity levels throughout the life course.
Mechanisms: current hypothesis for why South Asians are at increased risk of diabetes
Whether these patterns represent earlier beta cell 'exhaustion' secondary to higher levels of 211 insulin production needed throughout the life-course to compensate for insulin resistance; 
Do South Asians have a lower capacity for safe fat storage than Europeans?

219
In observational studies, the increase in diabetes risk per unit increase in BMI or waist 220 circumference is substantially greater in South Asians than Europeans (1;7) suggesting that 221 the adverse metabolic effects of increasing adiposity may be greater in South Asians. Indeed,
222
while South Asians carry more body fat than Europeans and this is distributed more centrally 223 (35-38), they remain more insulin resistant than Europeans after adjustment for a range of 224 adiposity markers (38-40). However, these relatively crude adjustments do not account for Europeans (45). However, recent evidence suggests that adipocyte size follows a bi-modal or 246 tri-modal distribution, which is not adequately described by simply reporting mean adipocyte 247 size (50-52). These studies suggest that insulin resistant obesity is characterised by an 248 increased proportion of small adipose cells (50;51) and larger large adipose cells (50;52).
249
This has been interpreted to reflect an inability for small adipose cells to terminally We have also reported that fat oxidation during sub-maximal exercise (which largely reflects 340 muscle metabolism) was about 50% lower in South Asian men compared with age and BMI-341 matched white European men, and that this was associated with lower insulin sensitivity at 342 both the whole body level and the level of insulin signalling within skeletal muscle (39).
343
However, paradoxically, despite lower cardiorespiratory fitness and fat oxidation during normoglycemic South Asian men had a lower mitochondrial to nuclear DNA ratio, but 349 similar expression of oxidative, lipid and glucose metabolism genes in skeletal muscle (88) .
350
In contrast, data from Nair and co-workers suggest that skeletal muscle capacity for oxidative 351 phosphorylation and mitochondrial DNA copy number may be higher, rather than lower, in Detailed examination of ectopic fat depots to include more data on liver fat and pancreatic fat as determinants of hepatic insulin resistance and pancreatic beta cell function, respectively. Detailed examination of SA adipose tissue phenotypic features across lifecourse and with intentional weight loss and weight gain.
Lean body mass
SA have a lower proportion of lean mass which appear to contribute to their higher insulin resistance and diabetes risk.
Interventions on the effects of resistance exercise to increase lean body mass on insulin resistance and diabetes risk in SA.
Fitness and skeletal muscle function SA have lower cardiorespiratory fitness (independent of physical activity level) and lower fat rates of fat oxidation during submaximal exercise. Both appear to contribute to their higher insulin resistance. However, from the available evidence it appears that skeletal muscle mitochondrial dysfunction is unlikely to account this.
Interventions using higher intensity exercise to maximise potential increases in fitness on insulin resistance and diabetes risk in SA. Studies to investigate whether impaired skeletal muscle microvascular function contributes to increased insulin resistance.
Lifestyle SAhave lower levels of physical activity than white Europeans.
No clear evidence for diet as major contributor to excess type 2 diabetes risk in migrant SA, but emerging data that SA may have greater adverse effects of shortterm overfeeding.
Development of novel, culturally appropriate approaches to increase physical activity across the life-course in SA. This is particularly important for SA girls where activity levels fall off rapidly by secondary school age. Trials of more intensive lifestyle interventions (greater amounts of physical activity, larger weight loss, and addition of resistance exercise) and/or earlier intervention (see below on widening 'high risk for diabetes' range).
Public health measures
In line with above, preliminary evidence that SA need to undergo more physical activity and achieve lower BMIs to mitigate metabolic risks. This is starting to be reflected in public health obesity guidance, but not yet in physical activity guidance.
More research needed to determine appropriate levels of physical activity to minimise diabetes risk in SA to inform public health guidelines. In addition, research needed on which public health measures could cost-effectively lower diabetes risk in SA both in developed and developing countries (e.g. sugary drinks tax, culturally tailored education programmes, engagement of community leaders and media stars as advocates). Approaches taken are likely to be culturally specific and may differ country by country. More research is needed on how to lessen glycaemia levels in SA with type 2 diabetes. Specific examples include: the potential role of dual therapy at diagnosis in select groups; and more frequent visits to monitor HbA1c and progress in early years after diagnosis. The efficacy and side effect profiles of different second line therapies in SA should be examined in the same way such approaches being examined in US (GRADE study). More research needed on how to improve compliance with diabetes medications and to stimulate /facilitate better adoption of lifestyle changes. Figure 4
Management
